Literature DB >> 35390097

COVID-19 vaccine acceptance, hesitancy, and associated factors among medical students in Sudan.

Saud Mohammed Raja1,2, Murwan Eissa Osman1, Abdelmageed Osman Musa1, Asim Abdelmoneim Hussien1, Kabirat Yusuf1.   

Abstract

BACKGROUND: The COVID-19 vaccination in Sudan launched in March 2021 but the extent of its acceptance has not been formally studied. This study aimed to determine the acceptance and hesitancy of the COVID-19 vaccine and associated factors among medical students in Sudan.
METHODS: A descriptive cross-sectional study was conducted using an online self-administered questionnaire designed on Google Form and sent to randomly-selected medical students via their Telegram accounts from 30th June to 11th July 2021. Data were analyzed using Statistical Package for Social Sciences software. Chi-square or Fisher's exact test and logistic regression were used to assess the association between vaccine acceptance and demographic as well as non-demographic factors.
RESULTS: Out of the 281 students who received the questionnaire, 220 (78%) responded, of whom 217 consented and completed the form. Males accounted for 46. 1%. Vaccine acceptance was 55. 8% (n = 121), and vaccine hesitancy was 44. 2% (n = 96). The commonly cited reasons for accepting the vaccine were to protect themselves and others from getting COVID-19. Concerns about vaccine safety and effectiveness were the main reasons reported by those who were hesitant. Factors associated with vaccine acceptance were history of COVID-19 infection (adjusted odds ratio (aOR) = 2. 2, 95% CI 1. 0-4.7, p = 0. 040), belief that vaccines are generally safe (aOR = 2.3, 95% CI 1. 2-4.5, p = 0.020), confidence that the vaccine can end the pandemic (aOR = 7.5, 95% CI 2. 5-22. 0, p<0.001), and receiving any vaccine in the past 5 years (aOR = 2.4, 95% CI 1.1-5.4, p = 0.031). No demographic association was found with the acceptance of the vaccine.
CONCLUSIONS: This study has revealed a high level of COVID-19 vaccine hesitancy among medical students. Efforts to provide accurate information on COVID-19 vaccine safety and effectiveness are highly recommended.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35390097      PMCID: PMC8989287          DOI: 10.1371/journal.pone.0266670

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

More than a year since its declaration of Coronavirus Disease 2019 (COVID-19) as a pandemic on 11 March 2020 [1], the disease is still causing enormous public health crisis globally with ongoing infections, mortality, and serious economic and social impact [2]. As of August 2021, Over 217 million people worldwide have been infected with the culprit virus named severe acute respiratory syndrome-2 (SARS-CoV-2) resulting in over 4. 5 million deaths [3]. Sadly, the COVID-19 pandemic is expected to keep on imposing huge morbidity and mortality and disrupt societies and economies globally [4]. Although several preventive and therapeutic measures have been attempted, the newly-developed vaccines have also been shown to be effective at minimizing the effect of COVID-19 [5]. Indeed, public health measures such as quarantine, social distancing, mask-wearing, and other non-pharmaceutical interventions played an important role in mitigating the spread of the pandemic [6]. Nevertheless, the rate of new infections and deaths is still on the rise. Several vaccines have been developed with some already authorized and others under clinical trials. Notably, the Pfizer/BioNtech, AstraZeneca, Moderna, and Johnson & Johnson’s Janssen COVID-19 vaccines are among the popular preparations approved for emergency use in several countries [7]. Regardless of the disproportionate distribution of the vaccines between high-income and low-income countries, vaccine hesitancy remains a significant barrier to the successful inoculation of the public [8]. According to the World Health Organization (WHO), vaccine hesitancy is defined as reluctance or refusal to vaccinate despite the availability of vaccines [9]. The WHO designated vaccine hesitancy as one of the ten threats to global health in 2019 [10]. Surprisingly, in the era of COVID-19, the problem is significant even among healthcare workers [11]. Medical students are future healthcare professionals who are considered open-minded and expected to respond quickly to public health measures. Unfortunately, a study conducted in the USA reported that nearly a quarter of the medical students were unwilling to get the COVID-19 vaccine as soon as the vaccines are approved [12]. Another study in India also showed that 10. 6% of medical students were hesitant to take the vaccine [13]. It has been reported that at least one in five healthcare trainees, on average, is hesitant for the COVID-19 vaccine [14]. In Africa, despite the scarcity of the vaccine itself, acceptability for it seems lower than in the developed world. A nationwide survey conducted among medical students in Uganda reported that more than a third of them were hesitant for the COVID-19 vaccine [15]. Several factors are associated with the acceptance of medical students for the vaccine. Importantly, the source of information plays a pivotal role [15]. The role of social media in spreading negative information about COVID-19 vaccination is evident. Not only is the pandemic at a continuous spread despite all the measures, disinformation and misinformation about the infection and the vaccine are also spreading at a similar pace, if not faster. The situation, known as "infodemic", has a strong impact on public health response to the COVID-19 pandemic [16]. Noticeably, medical students are expected to be influenced significantly as they are the age group where social media is pervasive. COVID-19 has been reported in Sudan since March 13, 2020. To date, more than thirty-seven thousand people have been infected with over 2,800 deaths [17]. Nearly a year after the first case, Sudan received over 800,000 doses of AstraZeneca vaccine on March 3, 2021, through COVID-19 Vaccines Global Access (COVAX) Facility [18] and vaccinations started on March 9 prioritizing healthcare workers, the aged population, and those with chronic medical conditions. Two shots of the vaccine have been delivered thereby allowing some people to get fully vaccinated. However, many medical professionals seem to be less enthusiastic about the vaccination roll-out. To the best of our knowledge, no study has been conducted in Sudan to address COVID-19 vaccine acceptance among medical students. Notably, medical students are an easily targetable population to be good role models in the community and foster positive public health opinions. Hence, we aimed to assess the acceptance and hesitancy for the COVID-19 vaccine and associated factors among medical students in Sudan.

Methods

Study design

We conducted an online, descriptive, cross-sectional, institution-based study.

Study area

The study was carried out at the International University of Africa (IUA), Faculty of Medicine. Based in Khartoum, Sudan, the faculty aims to qualify medical doctors for the diagnosis and treatment of endemic diseases and other health problems [19] who can fill the gap in the health workforce crisis. The faculty can accommodate more than a thousand medical students.

Study population

Fourth and fifth-year (clinical phase) medical students at the IUA, Faculty of Medicine were selected as the study population. At the time of the study, 471 medical students were enrolled in the two clinical phase years from which the sample population was recruited.

Inclusion and exclusion criteria

Medical students enrolled and active in their clinical year studies during the study period who joined the main social media group (Telegram) and consented to the study were included. Those who lacked access to the Internet were excluded.

Variables

Dependent variable: COVID-19 vaccine acceptance, hesitancy. Independent variables: COVID-19 vaccine safety, efficacy, perceived risk of COVID-19 infection or pandemic, prior COVID-19 infection, previous vaccination, confidence in the vaccine, source of information. Background variables: Age, gender, marital status, year of study, nationality.

Sampling

Sample size

The Miller and Brewer’s mathematical formula [20] was used to calculate the sample size from the total 471 medical students. n = N/[1+N(d) Where, N = the population size (471) d = the degree of accuracy required (0.05) n = 471/1+[471 (0.05)2] n = 216 (before adjusting for non-response) To adjust for the non-response rate, which was estimated to be up to 30%, the sample size was augmented as follows. Sample size for data collection = 216 + (0.3 x 216) = 281 After data collection, the final sample size that fulfilled the inclusion criteria and thus included in data analysis was 217.

Sampling technique

A simple random sampling technique was employed to recruit participants into the study. A list of the students (sampling frame) was obtained and randomly selected individuals were contacted.

Data collection methods

A validated questionnaire with closed-ended questions from previous studies by Kanyike et al [15] as well as El-Elimat and colleagues [21] was adapted and modified to suit the study participants. The questionnaire was developed in Google Form and a link of it was sent individually to randomly selected participants into their Telegram account obtained from the Telegram group of the students. To minimize the non-response rate, the coordinator for each group initially shared an announcement in the main group so that randomly selected students expect a message in their personal accounts. Data collection started on 30th June 2021 and ended on 11th July 2021. Two reminder messages more than 48 hours apart were sent both in the main group and to the Telegram account of the individual participants who didn’t respond quickly. When almost 90% of the sample size was reached and the response rate was minimal, a 24-hour deadline reminder was sent, after which receiving responses was terminated.

Data analysis

The fully completed forms were exported to Microsoft Excel for cleaning and coding. Cleaned data were fed into Statistical Package for Social Sciences program (SPSS) Version 23 for analysis. The categorical data were summarized frequencies and percentages. Associations between variables were assessed using the Chi-square test or Fischer’s exact test. The WHO definition of vaccine hesitancy [22] was adopted to categorize participants into those who accept the COVID-19 vaccine and hesitant ones. Binary logistic regression was applied for variables that showed statistically significant correlation to identify statistically significant predictor variables. A p-value <0.05 was considered statistically significant. Results were presented with graphs, charts, and tables as appropriate.

Ethics approval and consent to participate

The study was approved by an ethical clearance obtained from the IUA, Faculty of Medicine, and Deanship of Higher Education, Research, and Publications. Only adult participants voluntarily willing to take part in the study were included by accepting an electronic written informed consent at the initial page of the online questionnaire. The ethical principles related to the inclusion of human subjects were strictly followed as defined in the Nuremberg Code and the Declaration of Helsinki.

Results

Demographics

Out of the 281 randomly selected students who received the questionnaire, 220 (78%) responded, of whom 217 consented and completed the questionnaire. Three-quarters of the students were below or at the age of 24 years, with females slightly more than males, and nearly all students were single. More than two-thirds of the students were non-Sudanese. Table 1 summarizes the demographic characteristics of the participants.
Table 1

Demographic characteristics of medical students at IUA, Khartoum, Sudan, 2021 (n = 217).

DemographicsFrequencyPercentage
Age
    ≤ 2416174.2
    > 245625.8
Sex
    Male10046.1
    Female11753.9
Marital Status
    Single20996.3
    Married62.8
    Prefer not to say20.9
Year of study
    First clinical year (Year 4)9945.6
    Second clinical year (Year 5)11854.4
Nationality
    Sudanese6228.6
    Non-Sudanese15571.4

COVID-19 vaccine acceptance and hesitancy

The majority of the students (n = 121, 55.8%) accepted the vaccine. The most commonly reported reason for the acceptance of the vaccine was to protect themselves from getting the vaccine (nearly 80%), followed by both to protect others and to be able to travel. On the other hand, university recommendation was the least mentioned reason for taking the COVID-19 vaccine. Ninety-six (44.2%) students were not willing to take the COVID-19 vaccine, of whom 71 (32.7%) were not sure whether they would decide to take it and 25 (11.5%) reported that they made up their mind will not take the vaccine. Most participants were hesitant about the vaccination due to concerns related to the safety and effectiveness of the vaccine as well as the influence of negative information about the COVID-19 vaccine. Six participants clearly reported that they were against any form of vaccination. Table 2 summarizes the reasons for acceptance and hesitancy of the COVID-19 vaccine among the medical students.
Table 2

Reasons for acceptance and hesitancy of the COVID-19 vaccine among medical students at IUA, Khartoum, Sudan, 2021 (n = 121).

ReasonFrequencyPercentage
Reasons for accepting (n = 121)
    To protect myself from getting COVID-199679.3
    To protect others from getting COVID-197158.7
    To be able to travel7158.7
    I believe in vaccines and immunization5646.3
    I believe the vaccines are effective4738.8
    It is a social and moral responsibility4335.5
    To get rid of the virus and end the pandemic4133.9
    Health workers’ recommendations3629.8
    I believe the vaccines are safe3528.9
    Government recommendations1915.7
    Parent recommendations1814.9
    I am at high risk of severe disease54.1
    University recommendations21.7
Reasons for hesitancy (n = 91)
    I am concerned of the vaccine safety3839.6
    I am not sure of the vaccine effectiveness3536.5
    I have heard or read negative information about the vaccines3435.4
    I want to wait until more people take it1818.8
    I am young. I can recover easily if infected1313.5
    I do not believe it is important1313.5
    Vaccine development was rushed1313.5
    Someone I know had bad reaction after vaccination1111.5
    Someone else told me that the vaccine was not safe1010.4
    I feel I had enough immunity1010.4
    I am busy with my studies99.4
    I don’t know why99.4
    I had or maybe had COVID-19 infection already88.3
    I am against any form of vaccination66.3
    The vaccine brand I prefer was not available locally55.2
    I don’t know where to get vaccinated44.2
    I fear needles44.2

Factors associated with COVID-19 vaccine acceptance and hesitancy

Demographic factors, perceived risk of COVID-19 infection personally or to the public, the safety of vaccines in general, history of COVID-19 infection, and sources of information were assessed for association with acceptance or hesitancy of the COVID-19 vaccine among the students. As shown in Table 3, none of the demographic characteristics of the participants had a statistically significant correlation with vaccine acceptance and hesitancy. However, several other factors were found to be associated. Acceptance and hesitancy for the COVID-19 vaccine among the participants were significantly associated with consideration of COVID-19 as a public health threat, worry about the infection, belief of being the pandemic a threat to people in Sudan, the attitude that vaccines are generally safe, the trust that COVID-19 vaccination may end the pandemic, and having heard negative information about the COVID-19 vaccine. Table 4 summarizes the non-demographic associated factors and Fig 1 illustrates the source of information regarding the COVID-19 pandemic and its vaccine among the participants.
Table 3

Association of demographic characteristics with COVID-19 vaccine acceptance and hesitancy among medical students at IUA, Khartoum, Sudan, 2021 (n = 217).

VariablesAcceptance of COVID-19 vaccine
Yes (n = 121)No (n = 96)
frequency % frequency % Chi-Square p-value
Age
    ≤ 249257. 16942. 90. 4830. 487
    > 242951. 92748. 1
Sex
    Male575743430. 1150. 734
    Female6454. 75345. 3
Marital Status
    Single11555. 09445. 01. 990*0. 437
    Married583. 3116. 7
    Prefer not to say150. 0150. 0
Year of study
    Year 45454. 54545. 50. 1090. 741
    Year 56756. 85143. 2
Nationality
    Sudanese3759. 72540. 30. 5340. 462
    Non-Sudanese8454. 27145. 8

* Fisher’s exact test was done instead of Chi-square test.

Table 4

Non-demographic factors associated with COVID-19 vaccine acceptance and hesitancy among medical students at IUA, Khartoum, Sudan, 2021 (n = 217).

VariablesAcceptance of COVID-19 vaccine
Yes (n = 121)No (n = 96)
frequency % frequency % Chi-Square * p-value
Believes COVID-19 is a real public health threat at present.
    Yes9961. 96138. 110. 806*0. 010**
    No220. 0880. 0
    May be1742. 52357. 5
    Don’t know342. 9457. 1
Worried about COVID-19 infection.
    Not at all worried1740. 52559. 5
    Somewhat worried3068. 21431. 8
    Not very worried4453. 73846. 39. 563*0. 046**
    Very worried2765. 91434. 1
    Extremely worried337. 5562. 5
COVID-19 poses a risk to me personally.
    No risk at all1246. 21453. 8
    Minor risk2951. 82748. 2
    Moderate risk4360. 62839. 44. 5070. 342
    Major risk2167. 71032. 3
    Don’t know1648. 51751. 5
COVID-19 poses a risk to people in Sudan.
    No risk at all583. 5116. 712. 938*0. 010**
    Minor risk1140. 71659. 3
    Moderate risk3345. 24054. 8
    Major risk5568. 82531. 3
    I don’t know1754. 81445. 2
Estimated likelihood of getting COVID-19 infection in the future.
    Not at all1640. 02359. 04. 727*0. 317
    Slightly4557. 03443. 0
    Moderate3960. 92339. 1
    Very likely1858. 11341. 9
    Extremely likely375. 0125. 0
History of COVID-19 infection.
    No5752. 85147. 25. 7310. 125
    Yes, confirmed1372. 2527. 8
    Yes, not confirmed2965. 91534. 1
    Not sure2246. 82553. 2
In general, vaccines are safe.
    Disagree0-14100. 023. 5950. 000**
    Neutral2447. 12752. 9
    Agree7762. 64637. 4
    Strongly agree2069. 0931. 0
COVID-19 vaccine will end the pandemic if enough people in the world get it.
    Strongly disagree250. 0250. 041. 457*0. 000**
    Disagree521. 71878. 3
    Neutral2435. 34464. 7
    Agree6670. 22829. 8
    Strongly agree2485. 7414. 3
History of vaccination for other diseases in the last 5 years.
    Not vaccinated1441. 22058. 83. 573*0. 139
    Vaccinated10358. 97241. 1
    Don’t remember450. 0450. 0
Heard any negative information about the COVID-19 vaccine.
    No1173. 3426. 70. 047**
    Yes10656. 48243. 66. 103
    Not sure428. 61071. 4
Use of social media as an information source for COVID-19
    Yes6956. 15443. 90. 0130. 909
    No5255. 34244. 7

* Fisher’s exact test was conducted instead of Chi-square test.

** Statistically significant (p value <0. 05)

Fig 1

Sources of information regarding COVID-19 pandemic and vaccines among medical students at IUA, Khartoum, Sudan, 2021 (n = 217).

* Fisher’s exact test was done instead of Chi-square test. * Fisher’s exact test was conducted instead of Chi-square test. ** Statistically significant (p value <0. 05)

Predictors associated with vaccine acceptance among medical students

Table 5 shows how predictive the associated factors are for COVID-19 vaccine acceptance among the medical students when the logistic regression model was applied. Variables that were found to be predictive of the COVID-19 vaccine were history of COVID-19 infection, belief in the general safety of vaccines, the trust that the COVID-19 vaccine may end the pandemic, and vaccination for other diseases in the last five years. Notably, those who think the COVID-19 vaccine can end the pandemic if enough people in the world get vaccinated are more than seven times more likely to accept the COVID-19 vaccine than those who refute the possibility.
Table 5

Predictors of COVID-19 vaccine acceptance using logistic regression analysis among medical students at IUA, Khartoum, Sudan, 2021 (n = 217).

Predictors variable*Adjusted odds ratio (aOR)95% CIp-value
Believes that COVID-19 is a real public health threat at present.
    No/Maybe/Don’t knowReference
    Yes1. 70. 8–3. 50. 175
Worried about COVID-19 infection.
    Not worriedReference
    Worried2. 10. 9–4. 90. 076
COVID-19 poses a risk to people in Sudan.
    No/Minor riskReference
    Moderate/Major risk0. 90. 3–2. 20. 763
    Don’t know1. 00. 3–3. 50. 950
History of previous COVID-19 infection.
    No/Not sureReference
    Yes2. 21. 0–4. 70. 040**
In general, vaccines are safe.
    Disagree/NeutralReference
    Agree/Strongly agree2. 31. 2–4. 50. 020**
COVID-19 vaccine will end the pandemic if enough people in the world get it.
    Disagree/Strongly disagreeReference
    Neutral1. 50. 5–4. 60. 476
    Agree/Strongly agree7. 52. 5–22. 00. 000**
History of vaccination for other diseases in the last 5 years.
    No/Don’t rememberReference
    Yes2. 41. 1–5. 40. 031**
Heard any negative information about the COVID-19 vaccine.
    No/not sureReference
    Yes1. 10. 4–2. 70. 892

* Similar categories of responses of predictor variables are combined to avoid low count cells and make the logistic regression more accurate.

** Statistically significant.

CI = Confidence Interval.

* Similar categories of responses of predictor variables are combined to avoid low count cells and make the logistic regression more accurate. ** Statistically significant. CI = Confidence Interval.

Discussion

The WHO has earlier recognized vaccine hesitancy as one of the global health threats [10] and in the era of the COVID-19 pandemic, the issue has become of more concern than ever before [8]. Of note, COVID-19 vaccine hesitancy among healthcare workers, including medical students, has been recently reported to be a significant trend. This study aimed to find out the COVID-19 vaccine acceptance and hesitancy as well as associated factors among medical students at one of the leading medical schools in Sudan. To the best of our knowledge, this is the first study to address the situation among healthcare students in Sudan. This study revealed that 55. 8% of the medical students accepted the COVID-19 vaccine. This acceptance level is higher than reported among medical students in Uganda (37. 3%) [15] and Egypt (35%) [23]. The comparatively higher acceptance in this study could be due to the gradually increasing knowledge and trust of the vaccine unlike at the beginning of the vaccine rollout when the former studies were conducted. In contrast, the finding in this study was much lower compared to the acceptance rates among medical students in India (89. 4%) [13] and Poland (95. 9%) [24] as well as university students in Italy (94. 7%) [25]. The disparity in the burden of the COVID-19 pandemic in regions such as India and Europe compared to Africa could presumably justify the exceedingly higher acceptance in those highly affected areas than found in this study. The main reasons cited for accepting the vaccine were personal and others’ protection from COVID-19 infection, a finding similar to the Ugandan, Egyptian, and Polish studies [15, 23, 24]. Furthermore, more than half of the participants in this study reported accepting the vaccine for travel reasons, which is increasingly becoming important as "COVID-19 vaccine passports" are being introduced [26]. COVID-19 vaccine hesitancy among the medical students in this study was found to be 44. 2%. This rate of hesitancy is comparable with that reported in Egypt (47. 1%) [23] and among dental students in the USA (44%) [27]. However, the finding was higher in contrast to several studies conducted on medical students from Poland (4. 1%) [24], India (10. 6%) [13], USA (23%) [12], and the overall rate among healthcare students or workers from 39 countries (18. 9%) [14]. These discrepancies could be explained by the difference in the time of conducting the study, the disparity in the burden of COVID-19infection across the world, inconsistency in the exact definition of "vaccine hesitancy", and presumably the variable efforts of responsible bodies to minimize vaccine hesitancy both in the healthcare professionals and the public. Although this study was conducted among medical students in Sudan, more than two-thirds of the students at IUA come from various countries, mainly from neighboring African and Arab countries. The two main reasons for the COVID-19 vaccine hesitancy among the medical students in this study were concerns related to vaccine safety and effectiveness, as shown in Table 2. This is consistent with the bulk of the literature as reported by similar studies from Egypt [23],Uganda [15], India [13],USA [12],Turkey [28], Poland [29], Slovenia [30],and China [31] among others. More than a third of the COVID-19 vaccine-hesitant group also stated negative information about the vaccine as one of their main causes for deferring vaccination, in congruence with the study by Kanyike et al. [15]. Similarly, having heard or read negative information about the COVID-19 vaccines was also among the top grounds reported by the medical students for being hesitant regarding the vaccination. To date, no published report exists regarding the extent of COVID-19 vaccine hesitancy among the general population in Sudan. However, based on our findings, we can presume a similar or higher rate of hesitancy in the public, which needs to be confirmed in a further study. Apart from the vaccine safety and effectiveness concerns, the medical students in our study expressed their lack of confidence in the vaccine, and thus deferral of the vaccination, in various ways. Nearly one in five opted to wait and see until others take the vaccine. One in ten was influenced by someone who told them that the vaccine was unsafe or had suffered from an adverse reaction. Some participants believed the vaccine was unnecessary with a minority who showed the attitude of rejecting the concept of vaccination at all. A significant number of medical students thought being young and healthy would protect them from the pandemic. Of course, being busy students of medicine, lack of awareness of the local vaccination programs, and absence of access to the vaccine within reach kept certain participants hesitant. It is worth mentioning that some participants reported personal reasons for hesitancy that fitted one of the listed reasons in Table 2. We also addressed the factors associated with COVID-19 vaccine acceptance and hesitancy among the clinical phase students. In contrast to some studies [15, 23, 32] that have determined a significant association of demographic factors such as gender, marital status, or year of study with vaccine acceptance, this study did not find any statistically significant demographic correlation with the decision to accept or defer the COVID-19 vaccine among the medical students. This shows that the medical students were demographically similar without a demographic-based predilection for vaccination. Statistically significant association upon Chi-square or Fisher’s exact test were found with the belief of COVID-19 pandemic as a public health threat, being worried of the infection, perceived risk of the pandemic to people in Sudan, attitude to the general safety of vaccines, the role of the vaccine in ending the pandemic, and having heard negative information about the COVID-19 vaccine. These findings were consistent with the similar study conducted in Ugandan medical schools [15]. Indeed, the resemblance of the medical students between Uganda and Sudan and their shared characteristics would justify the comparable finding. After all, a significant proportion of IUA students come from various regions of Africa, thereby strengthening the likeness. Some associated factors can be utilized to predict COVID-19 vaccine acceptance using a binary logistic regression model. To that ends, upon utilizing the technique, statistically significant predictors of COVID-19 vaccine acceptance in this study were found to be prior infection with COVID-19, previous vaccination for other infections, the belief that vaccines are generally safe, and confidence that COVID-19 vaccination may end the pandemic. Of note, those who agreed that sufficient mass vaccination could end the pandemic were seven times more likely to accept the COVID-19 vaccine when compared to those who refuted the idea. This notion was not generally assessed in previous similar studies. In harmony with the findings of Kanyike et al., [15] this study determined that individuals previously vaccinated for other diseases are more likely to accept the new vaccine than those who didn’t. Contrary to the expectation assumed at the beginning of the study and in opposition to similar studies conducted by Kanyike et al. [15], Sallam et al. [33], and Saied et al. [23], relying on social media as a source of information was not found to be significantly associated with vaccine hesitancy among our medical students. This contradiction may be explained by the fact that the medical students generally use social media for most of the information they get, whether good or bad. In addition, unlike earlier during the pandemic and the rollout of the vaccine, positive information about successful vaccination against the pandemic is probably being promoted on social media. Nonetheless, medical students are undoubtedly encouraged to rely more on official sources of information and scientific articles in matters like this.

Limitations of the study

The current study sample was from a single medical school in Sudan. In addition, the majority of the students at IUA are foreigners. Hence, the results from this study may be difficult to project to all medical students in Sudan and may not represent the situation among healthcare professionals or trainees elsewhere in the country. Studying a single out of the numerous medical schools in Khartoum may not give a precise picture of the problem. Definition of vaccine hesitancy according to the WHO was adopted, where indecisive and those who refuse the vaccine are collectively categorized as vaccine-hesitant. However, due to the inconsistency in the literature, some comparisons might be slightly distorted. Since COVID-19 vaccination is not mandatory so far, those who got the vaccine were considered among the accepting group regardless of whether they were hesitant or not prior to vaccination irrespective of some strict technical definitions that may be contrary to the operational definition adopted in this study. Finally, knowledge of the students on COVID-19 and how it affects their decision to accept the vaccine was not assessed to keep the questionnaire a reasonable length for an adequate response. A visual summary of the main findings and the challenges or prospects of this study is provided in Fig 2.
Fig 2

Summary, challenges, or prospect of the present study.

Strengths of the study

We applied a random sampling technique to recruit participants, which was barely applied in other studies of the COVID-19 vaccine acceptance survey among healthcare personnel or trainees. On top of that, nearly 80% response rate was a huge achievement compared to several similar studies. This was obtained by choosing the most conducive time for sending the questionnaire and the prompts as well as sending highly appealing and respectful reminders to the participants. In addition, this is the first study to address the situation in Sudan.

Conclusions

In conclusion, this study has shown a relatively lower acceptance rate (55. 8%) for the COVID-19 vaccine and a high vaccine hesitancy state (44. 2%). We found that the main concern of the clinical phase students to defer the vaccine was related to skepticism about the safety and effectiveness of the COVID-19 vaccine corroborated by the widely pervasive negative news. In addition, the role of the University in providing accurate information regarding the pandemic and the vaccine was stated to be unsatisfactory. Hence, we recommend universities in Sudan provide accurate evidence-based information regarding the COVID-19 pandemic and its vaccines safety and efficacy to medical students. More efforts by the Ministry of Health and other governmental bodies are recommended to encourage healthcare trainees to accept the vaccine.

Raw data of participants.

(SAV) Click here for additional data file. 9 Nov 2021
PONE-D-21-29953
COVID-19 Vaccine Acceptance, Hesitancy, and Associated Factors among Medical Students in Sudan
PLOS ONE Dear Dr. Raja, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 24 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Sanjay Kumar Singh Patel, Ph.D. Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf  and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. 3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories 4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. 5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In this paper entitled “COVID-19 Vaccine acceptance, hesitancy, and associated factors among Medical students in Sudan”, the author investigates the hesitancy of the COVID-19 vaccine and associated factors among medical students in Sudan. A descriptive cross-sectional study was performed using online questionnaires to assess the association between vaccine acceptance and various factors. Although the sample size is small, the study provides knowledge about factors involved in the approval and hesitancy of the COVID-19 vaccine. It would be helpful to develop strategies to remove these hesitancies against the COVID-19 vaccine worldwide. Minor comments: 1) The statistical technique used in this study is commendable. However, could the authors explain how his results are significant with a small sample size? Also, the study was conducted at faculty that can accommodate more than 1000 medical students. So, what are the reasons primary medical students are not included? 2) The Manuscript concluded that there is a high hesitancy against the COVID-19 vaccine among medical students. However, the medical students are highly educated among whole population. Therefore, could authors explain the reasons behind hesitation among medical students in the discussion, which are different from similar studies mentioned in the manuscript. Also, is this hesitation present in the general population? 4) There are issues in the reference section. Please correct it accordingly. Reviewer #2: In the current research article entitled " COVID-19 Vaccine Acceptance, Hesitancy, and Associated Factors among Medical Students in Sudan", by Raja et al., have studied/surveyed to estimate determine the acceptance and hesitancy of the COVID-19 vaccine and associated factors among medical students in Sudan. Authors conducted using an online self-administered questionnaire designed on Google Form and sent to randomly-selected medical students via their Telegram accounts from 30th June to 11th July, 2021. Data were analyzed using Statistical Package for Social Sciences software. Chi-square or Fisher's exact test, and logistic regression were used to assess the association between vaccine acceptance and demographic as well as non-demographic factors. They found that, a high level of COVID-19 vaccine hesitancy among medical. This article addresses a research topic of great interest; however, this reviewer has certain suggestions that would help produce a more comprehensive overview of the topic: Suggestions: 1. What % of COVID-19 vaccine hesitancy is there in Sudan among whole population? 2. The authors may additionally provide one Figure as summary, challenges, or prospect of the present study. 2. The authors should cross-check all abbreviations in the manuscript. Initially, define in full name followed by abbreviation. 3. The English of manuscript can be polished (minor). 4. Authors should add a paragraph to discuss more about the cause of COVID-19 vaccine hesitancy among medical students in Sudan. ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
23 Mar 2022 Reviewers' comments and authors’ reply Reviewer 1 (Minor comments) 1) The statistical technique used in this study is commendable. However, could the authors explain how his results are significant with a small sample size? Also, the study was conducted at faculty that can accommodate more than 1000 medical students. So, what are the reasons primary medical students are not included? Thank you for commending our statistical techniques. Regarding the sample size, the minimum required sample size for the selected study population was calculated with an appropriate formula and the number of participants was successfully attained. Therefore, we believe the sample size is reasonably representative at least to the medical students whom the sample was drawn from. The faculty can indeed accommodate more than 1000 medical students in all their academic years. However, we selected those in their clinical years for the following reasons. First, due to the COVID-19 partial lockdown at the inception of the study, there were interruptions in the academic program and those in their clinical years were thought to be more suitable for inclusion due to their hospital attachments and relatively uninterrupted schedule. Second, the objective of the study was to conduct an online, simple random design survey. Clinical-year students were more active online in their Telegram groups for the sake of coordinating their clinical attachments. Therefore, they were more appropriate for sampling and more likely to meet the inclusion criteria. 2) The Manuscript concluded that there is a high hesitancy against the COVID-19 vaccine among medical students. However, the medical students are highly educated among whole population. Therefore, could authors explain the reasons behind hesitation among medical students in the discussion, which are different from similar studies mentioned in the manuscript. Also, is this hesitation present in the general population? A detailed discussion of the reasons behind hesitancy among the medical students has been added in lines 264 through 277. Unfortunately, no published study of COVID-19 hesitancy in the general population exists so far to compare our findings. We have mentioned that in the discussion and recommended such a study in the future. 3) There are issues in the reference section. Please correct it accordingly. References have been revised and issues resolved. Reviewer 2 (Suggestions) 1. What % of COVID-19 vaccine hesitancy is there in Sudan among whole population? Unfortunately, no published report currently exists in the literature regarding the percentage of COVID-19 vaccine hesitancy among the general population in Sudan. Investigating the degree of vaccine hesitancy in the whole population was beyond the scope of the study. This has now been mentioned in the discussion section and a recommendation made for a large-scale population study. 2. The authors may additionally provide one Figure as summary, challenges, or prospect of the present study. A new figure (Fig 2) has been added as suggested. 2. The authors should cross-check all abbreviations in the manuscript. Initially, define in full name followed by abbreviation. Abbreviations have been cross-checked and all issues corrected. 3. The English of manuscript can be polished (minor). The manuscript's English has been revised and polished both manually and with the help of the Grammarly app. 4. Authors should add a paragraph to discuss more about the cause of COVID-19 vaccine hesitancy among medical students in Sudan. A new paragraph has been added in the discussion section to discuss the cause of COVID-19 vaccine hesitancy in detail (lines 264 - 277). Submitted filename: Response to reviewers.docx Click here for additional data file. 25 Mar 2022 COVID-19 vaccine acceptance, hesitancy, and associated factors among medical students in Sudan PONE-D-21-29953R1 Dear Dr. Raja, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Sanjay Kumar Singh Patel, Ph.D. Academic Editor PLOS ONE 30 Mar 2022 PONE-D-21-29953R1 COVID-19 vaccine acceptance, hesitancy, and associated factors among medical students in Sudan Dear Dr. Raja: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Sanjay Kumar Singh Patel Academic Editor PLOS ONE
  26 in total

1.  Vaccine hesitancy: Definition, scope and determinants.

Authors:  Noni E MacDonald
Journal:  Vaccine       Date:  2015-04-17       Impact factor: 3.641

2.  COVID-19 vaccine hesitancy among medical students in India.

Authors:  Jyoti Jain; Suman Saurabh; Prashant Kumar; Mahendra Kumar Verma; Akhil Dhanesh Goel; Manoj Kumar Gupta; Pankaj Bhardwaj; Pankaja Ravi Raghav
Journal:  Epidemiol Infect       Date:  2021-05-20       Impact factor: 2.451

3.  Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.

Authors:  Jamie Lopez Bernal; Nick Andrews; Charlotte Gower; Chris Robertson; Julia Stowe; Elise Tessier; Ruth Simmons; Simon Cottrell; Richard Roberts; Mark O'Doherty; Kevin Brown; Claire Cameron; Diane Stockton; Jim McMenamin; Mary Ramsay
Journal:  BMJ       Date:  2021-05-13

4.  COVID-19 vaccine passport for safe resumption of travel.

Authors:  Androula Pavli; Helena C Maltezou
Journal:  J Travel Med       Date:  2021-06-01       Impact factor: 8.490

5.  Dental students' attitudes and hesitancy toward COVID-19 vaccine.

Authors:  Ana Karina Mascarenhas; Victoria C Lucia; Arati Kelekar; Nelia M Afonso
Journal:  J Dent Educ       Date:  2021-04-29       Impact factor: 2.313

6.  COVID-19 vaccine hesitancy among medical students.

Authors:  Victoria C Lucia; Arati Kelekar; Nelia M Afonso
Journal:  J Public Health (Oxf)       Date:  2020-12-26       Impact factor: 2.341

7.  Challenges in the rollout of COVID-19 vaccines worldwide.

Authors:  Talha Khan Burki
Journal:  Lancet Respir Med       Date:  2021-03-05       Impact factor: 30.700

8.  Nursing students' attitudes, knowledge and willingness of to receive the coronavirus disease vaccine: A cross-sectional study.

Authors:  Ning Jiang; Baojian Wei; Hua Lin; Youjuan Wang; Shouxia Chai; Wei Liu
Journal:  Nurse Educ Pract       Date:  2021-07-13       Impact factor: 2.281

9.  WHO Declares COVID-19 a Pandemic.

Authors:  Domenico Cucinotta; Maurizio Vanelli
Journal:  Acta Biomed       Date:  2020-03-19

10.  COVID-19-Related Infodemic and Its Impact on Public Health: A Global Social Media Analysis.

Authors:  Md Saiful Islam; Tonmoy Sarkar; Sazzad Hossain Khan; Abu-Hena Mostofa Kamal; S M Murshid Hasan; Alamgir Kabir; Dalia Yeasmin; Mohammad Ariful Islam; Kamal Ibne Amin Chowdhury; Kazi Selim Anwar; Abrar Ahmad Chughtai; Holly Seale
Journal:  Am J Trop Med Hyg       Date:  2020-10       Impact factor: 3.707

View more
  4 in total

1.  COVID-19 Vaccine Hesitancy among Healthcare Workers and Trainees in Freetown, Sierra Leone: A Cross-Sectional Study.

Authors:  Sahr A Yendewa; Manal Ghazzawi; Peter B James; Mohamed Smith; Samuel P Massaquoi; Lawrence S Babawo; Gibrilla F Deen; James B W Russell; Mohamed Samai; Foday Sahr; Sulaiman Lakoh; Robert A Salata; George A Yendewa
Journal:  Vaccines (Basel)       Date:  2022-05-11

Review 2.  Global Prevalence and Potential Influencing Factors of COVID-19 Vaccination Hesitancy: A Meta-Analysis.

Authors:  Jonny Karunia Fajar; Malik Sallam; Gatot Soegiarto; Yani Jane Sugiri; Muhammad Anshory; Laksmi Wulandari; Stephanie Astrid Puspitasari Kosasih; Muhammad Ilmawan; Kusnaeni Kusnaeni; Muhammad Fikri; Frilianty Putri; Baitul Hamdi; Izza Dinalhaque Pranatasari; Lily Aina; Lailatul Maghfiroh; Fernanda Septi Ikhriandanti; Wa Ode Endiaverni; Krisna Wahyu Nugraha; Ory Wiranudirja; Sally Edinov; Ujang Hamdani; Lathifatul Rosyidah; Hanny Lubaba; Rinto Ariwibowo; Riska Andistyani; Ria Fitriani; Miftahul Hasanah; Fardha Ad Durrun Nafis; Fredo Tamara; Fitri Olga Latamu; Hendrix Indra Kusuma; Ali A Rabaan; Saad Alhumaid; Abbas Al Mutair; Mohammed Garout; Muhammad A Halwani; Mubarak Alfaresi; Reyouf Al Azmi; Nada A Alasiri; Abeer N Alshukairi; Kuldeep Dhama; Harapan Harapan
Journal:  Vaccines (Basel)       Date:  2022-08-19

3.  COVID-19 Impact on Public Dental Healthcare in Bosnia and Herzegovina: Current Situation and Ongoing Perspectives.

Authors:  Elmedin Bajrić; Amila Zukanović; Nina Marković; Amra Arslanagić; Amina Huseinbegović; Mediha Selimović-Dragaš; Sedin Kobašlija; Aleksandra Popovac; Dejan Marković
Journal:  Int J Environ Res Public Health       Date:  2022-09-19       Impact factor: 4.614

4.  Acceptance of coronavirus disease 2019 (COVID-19) vaccines among healthcare workers: A meta-analysis.

Authors:  Linlin Wang; Ye Wang; Xianbin Cheng; Xingzhao Li; Yanyan Yang; Jun Li
Journal:  Front Public Health       Date:  2022-09-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.